Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Authors:
Matthews, GV
Moyle, GJ
Mandalia, S
Bower, M
Nelson, M
Gazzard, BG
Citation: Gv. Matthews et al., Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initialtherapy, J ACQ IMM D, 24(4), 2000, pp. 310-315
Authors:
Francis, R
Bower, M
Brunstrom, G
Holden, L
Newlands, ES
Rustin, GJS
Seckl, MJ
Citation: R. Francis et al., Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options, EUR J CANC, 36(15), 2000, pp. 1925-1932
Authors:
Al-Shahi, R
Bower, M
Nelson, MR
Gazzard, BG
Citation: R. Al-shahi et al., Cerebrospinal fluid Epstein-Barr virus detection preceding HIV-associated primary central nervous system lymphoma by 17 months, J NEUROL, 247(6), 2000, pp. 471-472
Authors:
Doherty, AP
Bower, M
Smith, GL
Miano, R
Mannion, EM
Mitchell, H
Christmas, TJ
Citation: Ap. Doherty et al., Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival, BR J CANC, 83(11), 2000, pp. 1432-1436
Authors:
Matthews, GV
Bower, M
Mandalia, S
Powles, T
Nelson, MR
Gazzard, BG
Citation: Gv. Matthews et al., Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy, BLOOD, 96(8), 2000, pp. 2630-2634
Authors:
Matthews, GV
Bower, M
Mandalia, S
Powles, T
Nelson, MR
Gazzard, BG
Citation: Gv. Matthews et al., Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy, BLOOD, 96(8), 2000, pp. 2730-2734
Authors:
Bower, M
Fox, P
Fife, K
Gill, J
Nelson, M
Gazzard, B
Citation: M. Bower et al., Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma, AIDS, 13(15), 1999, pp. 2105-2111
Authors:
Balesaria, S
Brock, C
Bower, M
Clark, J
Nicholson, SK
Lewis, P
de Sanctis, S
Evans, H
Peterson, D
Mendoza, N
Glaser, MG
Newlands, ES
Fisher, RA
Citation: S. Balesaria et al., Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas, BR J CANC, 81(8), 1999, pp. 1371-1377
Authors:
Harper-Wynne, C
English, J
Meyer, L
Bower, M
Archer, C
Sinnett, HD
Lowdell, C
Coombes, RC
Citation: C. Harper-wynne et al., Randomized trial to compare the efficacy and toxicity of cyclophosphamide,methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast, BR J CANC, 81(2), 1999, pp. 316-322
Authors:
Fife, K
Howard, MR
Gracie, F
Phillips, RH
Bower, M
Citation: K. Fife et al., Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre, INT J STD A, 9(12), 1998, pp. 751-755